Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease

Background Advanced brain MR techniques are useful tools for differentiating Progressive Supranuclear Palsy from Parkinson's disease, although time-consuming and unlikely to be used all together in routine clinical work. We aimed to compare the diagnostic accuracy of quantitative morphometric, volumetric and DTI metrics for differentiating Progressive Supranuclear Palsy-Richardson's Syndrome from Parkinson's disease. Methods 23 Progressive Supranuclear Palsy-Richardson's Syndrome and 42 Parkinson's disease patients underwent a standardized 1.5T brain MR protocol comprising high-resolution T1W1 and DTI sequences. Brainstem and cerebellar peduncles morphometry, automated volumetric analysis of brain deep gray matter and DTI metric analyses of specific brain structures were carried out. We determined diagnostic accuracy, sensitivity and specificity of MR-markers with respect to the clinical diagnosis by using univariate receiver operating characteristics curve analyses. Age-adjusted multivariate receiver operating characteristics analyses were then conducted including only MR-markers with a sensitivity and specificity exceeding 80%. Results Morphometric markers (midbrain area, pons to midbrain area ratio and MR Parkinsonism Index), DTI parameters (infratentorial structures) and volumetric analysis (thalamus, putamen and pallidus nuclei) presented moderate to high diagnostic accuracy in discriminating Progressive Supranuclear Palsy-Richardson's Syndrome from Parkinson's disease, with midbrain area showing the highest diagnostic accuracy (99%) (mean ± standard deviation: 75.87 ± 16.95 mm2vs 132.45 ± 20.94 mm2, respectively; p < 0.001). Conclusion Although several quantitative brain MR markers provided high diagnostic accuracy in differentiating Progressive Supranuclear Palsy-Richardson's Syndrome from Parkinson's disease, the morphometric assessment of midbrain area is the best single diagnostic marker and should be routinely included in the neuroradiological work-up of parkinsonian patients.

[1]  W. Oertel,et al.  Magnetic resonance imaging in progressive supranuclear palsy , 2011, Journal of Neurology.

[2]  A Yagishita,et al.  New and reliable MRI diagnosis for progressive supranuclear palsy , 2005, Neurology.

[3]  W. Poewe,et al.  Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain‐to‐pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy , 2010, Movement disorders : official journal of the Movement Disorder Society.

[4]  D. Dickson,et al.  Neuropathology of variants of progressive supranuclear palsy. , 2010, Current opinion in neurology.

[5]  Z. Wszolek,et al.  New and reliable MRI diagnosis for progressive supranuclear palsy , 2006, Neurology.

[6]  Jiunjie Wang,et al.  Microstructural changes in patients with progressive supranuclear palsy: A diffusion tensor imaging study , 2010, Journal of magnetic resonance imaging : JMRI.

[7]  David R Williams,et al.  Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges , 2009, The Lancet Neurology.

[8]  M. Schocke,et al.  Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s Disease , 2010, Neurodegenerative Diseases.

[9]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[10]  Janey Prodoehl,et al.  Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor , 2013, Movement disorders : official journal of the Movement Disorder Society.

[11]  Aldo Quattrone,et al.  Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[12]  Raffaele Lodi,et al.  Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. , 2009, Brain : a journal of neurology.

[13]  P. Bruin,et al.  Morphometry MRI in the differential diagnosis of parkinsonian syndromes. , 2010, Arquivos de neuro-psiquiatria.

[14]  J A Swets,et al.  Measuring the accuracy of diagnostic systems. , 1988, Science.

[15]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[16]  A. Quattrone,et al.  Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[17]  F. Tison,et al.  Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.

[18]  I Litvan,et al.  Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[19]  H. Shill,et al.  Low clinical diagnostic accuracy of early vs advanced Parkinson disease , 2014, Neurology.

[20]  S. Fujii,et al.  Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging , 2012, Neuroradiology.

[21]  M. Skalej,et al.  Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.

[22]  Nick C Fox,et al.  Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy , 2005, Neurology.

[23]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[24]  Francesco Fera,et al.  MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. , 2008, Radiology.

[25]  C Kremser,et al.  Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy , 2003, Neurology.

[26]  J. Currie,et al.  Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. , 2002, Brain : a journal of neurology.

[27]  Aldo Quattrone,et al.  Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. , 2013, Radiology.

[28]  M. Filippi,et al.  MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy‐parkinsonism, and Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[29]  W. Oertel,et al.  Accuracy of the national institute for neurological disorders and stroke/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy , 2013, Movement disorders : official journal of the Movement Disorder Society.

[30]  Nick C Fox,et al.  Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy , 2012, Movement disorders : official journal of the Movement Disorder Society.

[31]  Nick C Fox,et al.  Regional brain volumes distinguish PSP, MSA‐P, and PD: MRI‐based clinico‐radiological correlations , 2006, Movement disorders : official journal of the Movement Disorder Society.